Barclays’s Verastem VSTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $479K | Sell |
90,300
-111,545
| -55% | -$688K | ﹤0.01% | 3213 |
|
|
2025
Q4 | $1.56M | Buy |
201,845
+33,470
| +20% | +$298K | ﹤0.01% | 3107 |
|
|
2025
Q3 | $1.49M | Sell |
168,375
-25,268
| -13% | -$188K | ﹤0.01% | 3108 |
|
|
2025
Q2 | $804K | Buy |
193,643
+151,495
| +359% | +$949K | ﹤0.01% | 3483 |
|
|
2025
Q1 | $254K | Sell |
42,148
-19,297
| -31% | -$118K | ﹤0.01% | 3914 |
|
|
2024
Q4 | $318K | Buy |
61,445
+5,737
| +10% | +$22.6K | ﹤0.01% | 4087 |
|
|
2024
Q3 | $167K | Buy |
55,708
+47,094
| +547% | +$128K | ﹤0.01% | 4383 |
|
|
2024
Q2 | $25.7K | Sell |
8,614
-22,447
| -72% | -$185K | ﹤0.01% | 4394 |
|
|
2024
Q1 | $367K | Buy |
31,061
+30,000
| +2,828% | +$347K | ﹤0.01% | 3777 |
|
|
2023
Q4 | $8.64K | Sell |
1,061
-3,786
| -78% | -$27.2K | ﹤0.01% | 4980 |
|
|
2023
Q3 | $39.4K | Sell |
4,847
-21,214
| -81% | -$204K | ﹤0.01% | 3962 |
|
|
2023
Q2 | $194K | Buy |
26,061
+24,999
| +2,354% | +$173K | ﹤0.01% | 3260 |
|
|
2023
Q1 | $5.29K | Hold |
1,062
| – | – | ﹤0.01% | 4810 |
|
|
2022
Q4 | $5.13K | Sell |
1,062
-1,022
| -49% | -$5.02K | ﹤0.01% | 4998 |
|
|
2022
Q3 | $21K | Buy |
2,084
+897
| +76% | +$12.5K | ﹤0.01% | 4050 |
|
|
2022
Q2 | $16K | Sell |
1,187
-2,319
| -66% | -$36.9K | ﹤0.01% | 4491 |
|
|
2022
Q1 | $60K | Sell |
3,506
-13,930
| -80% | -$240K | ﹤0.01% | 4044 |
|
|
2021
Q4 | $429K | Buy |
17,436
+11,457
| +192% | +$362K | ﹤0.01% | 3267 |
|
|
2021
Q3 | $220K | Sell |
5,979
-54
| -0.9% | -$1.98K | ﹤0.01% | 3569 |
|
|
2021
Q2 | $295K | Sell |
6,033
-5,936
| -50% | -$247K | ﹤0.01% | 3360 |
|
|
2021
Q1 | $355K | Buy |
11,969
+7,314
| +157% | +$205K | ﹤0.01% | 3400 |
|
|
2020
Q4 | $119K | Sell |
4,655
-1,867
| -29% | -$37.5K | ﹤0.01% | 4055 |
|
|
2020
Q3 | $95K | Sell |
6,522
-1,658
| -20% | -$27.4K | ﹤0.01% | 4282 |
|
|
2020
Q2 | $168K | Buy |
+8,180
| New | +$216K | ﹤0.01% | 4192 |
|
|
2020
Q1 | – | Sell |
-37
| Closed | -$1K | – | 6482 |
|
|
2019
Q4 | $1K | Sell |
37
-532
| -93% | -$7.65K | ﹤0.01% | 6283 |
|
|
2019
Q3 | $9K | Sell |
569
-15,415
| -96% | -$250K | ﹤0.01% | 6381 |
|
|
2019
Q2 | $289K | Buy |
15,984
+10,960
| +218% | +$248K | ﹤0.01% | 4789 |
|
|
2019
Q1 | $178K | Buy |
5,024
+2,554
| +103% | +$101K | ﹤0.01% | 4909 |
|
|
2018
Q4 | $99K | Sell |
2,470
-2,500
| -50% | -$153K | ﹤0.01% | 5049 |
|
|
2018
Q3 | $432K | Buy |
4,970
+4,647
| +1,439% | +$462K | ﹤0.01% | 4396 |
|
|
2018
Q2 | $27K | Buy |
+323
| New | +$19.8K | ﹤0.01% | 6024 |
|
|
2018
Q1 | – | Sell |
-3
| Closed | – | – | 7362 |
|
|
2017
Q4 | $0 | Sell |
3
-72
| -96% | -$3.25K | ﹤0.01% | 7150 |
|
|
2017
Q3 | $4K | Buy |
+75
| New | +$3.54K | ﹤0.01% | 6520 |
|
|
2016
Q3 | – | Sell |
-258
| Closed | -$4K | – | 6815 |
|
|
2016
Q2 | $4K | Buy |
+258
| New | +$4.54K | ﹤0.01% | 5807 |
|
|
2016
Q1 | – | Sell |
-17
| Closed | – | – | 6466 |
|
|
2015
Q4 | $0 | Sell |
17
-1,041
| -98% | -$24.7K | ﹤0.01% | 6630 |
|
|
2015
Q3 | $13K | Buy |
1,058
+1,002
| +1,789% | +$79.3K | ﹤0.01% | 5671 |
|
|
2015
Q2 | $5K | Sell |
56
-82
| -59% | -$8.67K | ﹤0.01% | 6466 |
|
|
2015
Q1 | $17K | Sell |
138
-136
| -50% | -$14.3K | ﹤0.01% | 5922 |
|
|
2014
Q4 | $30K | Sell |
274
-18
| -6% | -$1.95K | ﹤0.01% | 6064 |
|
|
2014
Q3 | $28K | Sell |
292
-252
| -46% | -$26.4K | ﹤0.01% | 6269 |
|
|
2014
Q2 | $59K | Buy |
544
+131
| +32% | +$14.2K | ﹤0.01% | 5825 |
|
|
2014
Q1 | $50K | Sell |
413
-46
| -10% | -$7.34K | ﹤0.01% | 5999 |
|
|
2013
Q4 | $60K | Sell |
459
-512
| -53% | -$67.3K | ﹤0.01% | 6060 |
|
|
2013
Q3 | $140K | Buy |
971
+908
| +1,441% | +$159K | ﹤0.01% | 5351 |
|
|
2013
Q2 | $10K | Buy |
+63
| New | +$7.59K | ﹤0.01% | 7142 |
|
Other funds holding VSTM
RI
DTC
AC
NCM
VCM
SCM
FCMV
Barclays's VSTM Position: Q1 2026 in Review
Barclays reduced its Verastem (VSTM) stake by 55% in Q1 2026, selling an estimated $688K and leaving 90,300 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.
Barclays first reported a position in VSTM in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.56M in Q4 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.
- Barclays held 90,300 shares of Verastem worth $479K as of Q1 2026.
- Barclays sold 111,545 Verastem shares in Q1 2026, an estimated $688K.
- Verastem made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3213 holding.
- Barclays first reported a position in Verastem in Q2 2013 and has held it in 45 quarters since.
- Barclays's Verastem position peaked at $1.56M in Q4 2025.
- 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.